Your browser doesn't support javascript.
loading
TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer.
Li, Zequn; Cao, Shougen; Sun, Yuqi; Niu, Zhaojian; Liu, Xiaodong; Niu, Jun; Zhou, Yanbing.
Affiliation
  • Li Z; Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
  • Cao S; Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
  • Sun Y; Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
  • Niu Z; Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
  • Liu X; Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
  • Niu J; Department of General Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
  • Zhou Y; Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China. qdfyzhouyanbing@163.com.
Mol Cancer ; 21(1): 160, 2022 08 09.
Article de En | MEDLINE | ID: mdl-35941647

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Mol Cancer Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Mol Cancer Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Chine